WuXi AppTec Co., Ltd. (FRA:WX8)

Germany flag Germany · Delayed Price · Currency is EUR
11.20
+0.10 (0.90%)
Last updated: Dec 5, 2025, 3:29 PM CET
82.11%
Market Cap 32.77B
Revenue (ttm) 5.25B
Net Income (ttm) 1.79B
Shares Out n/a
EPS (ttm) 0.56
PE Ratio 18.26
Forward PE 17.79
Dividend 0.21 (1.84%)
Ex-Dividend Date Sep 8, 2025
Volume n/a
Average Volume 154
Open 11.20
Previous Close 11.10
Day's Range 11.20 - 11.20
52-Week Range 5.30 - 13.80
Beta n/a
RSI 46.92
Earnings Date Mar 15, 2026

About WuXi AppTec

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally. The company operates through WuXi Chemistry, WuXi Testing, WuXi Biology, and Others segments. It offers contract research, development, and manufacturing organization (CDRMO) services for new drug development from discovery to commercial covering various categories for various synthetic molecula... [Read more]

Industry Commercial Physical and Biological Research
Founded 2000
Employees 39,414
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol WX8
Full Company Profile

Financial Performance

In 2024, WuXi AppTec's revenue was 37.92 billion, a decrease of -1.97% compared to the previous year's 38.68 billion. Earnings were 9.45 billion, a decrease of -1.63%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.